Background: Although more than 150,000 implantable cardioverter defibrillators (ICDs) are implanted yearly worldwide, only few studies systematically examined complications of ICD therapy in large ...

Please provide your email address to receive an email when new articles are posted on . Abbott announced that a cardiac resynchronization therapy defibrillator and an implantable cardioverter ...

The risk associated with implantation of the implantable cardioverter-defibrillator (ICD) is often focused on the immediate complications of the procedure. The long-term risk of having an ICD, ...

Dublin, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The "Implantable Cardioverter Defibrillators (ICD) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key ...

The US FDA study is intended to evaluate the system for treating life-threatening ventricular tachyarrhythmias.

Medtronic has received U.S. regulatory approval to sell a new implantable defibrillator that can be placed outside of the heart and veins to treat SCA — sudden cardiac arrest — an electrical problem ...

A standard test of the implantable cardioverter defibrillator (ICD) is linked to significant thought-processing problems that improve for most patients within a year after the device is inserted, ...

Short- and long-term risks of ventricular tachycardia or ventricular fibrillation, and of recurrent events, are related to the presence of transient or persistent physiological factors. Ventricular ...

A wearable automatic defibrillator may be an alternative to an implantable cardiac defibrillator for a small group of patients, say researchers. There are few large, randomized and controlled clinical ...

Heart failure is a deadly disease. Every year, tens of thousands of patients die from this condition, many of them suddenly. Efforts aimed at reducing mortality centered initially on antagonizing the ...